DyAnsys wins FDA approval for First Relief neurostimulation device
Made for diabetic peripheral neuropathy pain, the wearable device monitors pulses of a low-level electrical current over several…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
15 Jul 22
Made for diabetic peripheral neuropathy pain, the wearable device monitors pulses of a low-level electrical current over several…
15 Jul 22
A blood test could predict risk of developing leukaemia in the elderly population years in advance by identifying…
15 Jul 22
The DNA/RNA Shield™ product line includes sample collection, preservation, and transportation devices for specimens used in research and…
14 Jul 22
The new blood test measures NfL levels, an important biomarker associated with neuronal damage, and helps diagnose diseases,…
14 Jul 22
The partnership will advance the making and distribution of electrocardiogram AI algorithms to identify and treat patients with…
14 Jul 22
The collaboration will enable existing Siemens clients to save more time and offer improved image quality, optimised workflow,…
14 Jul 22
REACH, a Phase 3 Clinical Trial of losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD) utilizes AMRA's Muscle Fat Infiltration…
14 Jul 22
As the first self-expanding TPVR product approved for marketing in both China and Europe, VenusP-ValveTM sets itself apart…
13 Jul 22
The company designed AccuCinch System to provide a minimally invasive transcatheter therapy for patients living with symptomatic heart…
13 Jul 22
The solution is claimed to be the first and only machine-learning algorithm to help healthcare professionals in detecting…